| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.4B | $1.4B | $1.2B | 3.0% | 19.4% |
| Op. Income | $156M | $126M | $177M | 23.4% | -11.8% |
| Gross Margin | 27.2% | 28.8% | 34.6% | -1.5pp | -7.3pp |
| Net Margin | 7.7% | 6.5% | 11.7% | 1.2pp | -4.0pp |
| EPS (Diluted) | $1.91 | $1.56 | $2.37 | 22.4% | -19.4% |
| Free Cash Flow | $286M | $43M | $237M | 560.4% | 20.8% |
| Item | Amount |
|---|---|
| REVENUE | $1.4B |
| Cost of Revenue | $1.0B |
| GROSS PROFIT | $380M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $224M |
| Other Expenses | $0 |
| Operating Expenses | $224M |
| Cost & Expenses | $1.2B |
| OPERATING INCOME | $156M |
| Interest Income | $4M |
| Interest Expense | $0 |
| Other Income/Expenses | -$12M |
| INCOME BEFORE TAX | $144M |
| Income Tax Expense | $37M |
| Net Income from Continuing Ops | $107M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $107M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $107M |
| D&A | $31M |
| EBIT | $144M |
| EBITDA | $175M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $1.4B |
| Cost of Revenue | $1.0B |
| GROSS PROFIT | $380M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $224M |
| Other Expenses | $0 |
| Operating Expenses | $224M |
| Cost & Expenses | $1.2B |
| OPERATING INCOME | $156M |
| Interest Income | $4M |
| Interest Expense | $0 |
| Other Income/Expenses | -$12M |
| INCOME BEFORE TAX | $144M |
| Income Tax Expense | $37M |
| Net Income from Continuing Ops | $107M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $107M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $107M |
| D&A | $31M |
| EBIT | $144M |
| EBITDA | $175M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $107M |
| Depreciation & Amortization | $31M |
| Stock-Based Compensation | $45M |
| Deferred Income Tax | $9M |
| Other Non-Cash Items | -$151M |
| Change in Working Capital | $254M |
| OPERATING CASH FLOW | $295M |
| Capital Expenditure | -$8M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$9M |
| NET CASH FROM INVESTING | -$9M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$82M |
| Common Dividends Paid | $0 |
| Other Financing Activities | -$39M |
| NET CASH FROM FINANCING | -$86M |
| FREE CASH FLOW | $286M |
| Net Change in Cash | $197M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.2B |
| Short-Term Investments | $0 |
| Net Receivables | $1.1B |
| Inventory | $0 |
| Other Current Assets | $154M |
| TOTAL CURRENT ASSETS | $2.5B |
| PP&E (Net) | $322M |
| Goodwill | $1.2B |
| Intangible Assets | $420M |
| Long-Term Investments | $0 |
| Tax Assets | $235M |
| Other Non-Current Assets | $133M |
| TOTAL NON-CURRENT ASSETS | $2.3B |
| TOTAL ASSETS | $4.8B |
| Account Payables | $43M |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $189M |
| TOTAL CURRENT LIABILITIES | $835M |
| Long-Term Debt | $25M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $97M |
| Other Non-Current Liabilities | $69M |
| TOTAL NON-CURRENT LIABILITIES | $281M |
| TOTAL LIABILITIES | $1.1B |
| Common Stock | $55.0K |
| Additional Paid-In Capital | $1.3B |
| Retained Earnings | $2.4B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $12M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $3.7B |
| Minority Interest | $582.0K |
| TOTAL EQUITY | $3.7B |
| TOTAL LIABILITIES & EQUITY | $4.8B |
| Total Debt | $155M |
| Net Debt | -$1.1B |
